SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
SelectQuote (NYSE:SLQT) reported Q4 FY2025 consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company posted net income of $12.9 million, compared to a net loss of $31.0 million in the prior year period. Adjusted EBITDA was $2.7 million, down from $14.4 million year-over-year.
The company's Healthcare Services segment showed strong growth with revenue of $214.0 million, up 47% year-over-year, while SelectRx members increased 31% to 108,018. The Senior segment revenue declined 28% to $82.5 million, with Medicare Advantage approved policies decreasing 20% to 85,344.
For FY2026, SelectQuote guides revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.
SelectQuote (NYSE:SLQT) reported Q4 FY2025 results with consolidated revenue of $345.1 million, up from $307.2 million in Q4 FY2024. The company achieved net income of $12.9 million, a significant improvement from a $31.0 million loss in the prior year period, though Adjusted EBITDA decreased to $2.7 million from $14.4 million.
The company's performance was driven by three segments: Senior ($82.5M revenue), Healthcare Services ($214.0M revenue), and Life ($48.0M revenue). Healthcare Services showed strong growth with SelectRx members increasing 31% to 108,018. For FY2026, SelectQuote projects revenue between $1.65-1.75 billion and Adjusted EBITDA of $120-150 million.
SelectQuote (NYSE:SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal fourth quarter and full year 2025 earnings release for August 21, 2025, before market open.
CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss the results. Interested parties can register for the call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on the company's investor relations website.
SelectQuote (NYSE:SLQT) announced the expanded launch of a new concierge-like service through its SelectRx pharmacy, designed to improve medication adherence for Medicare beneficiaries with multiple chronic conditions. A recent trial with a regional health plan demonstrated over 90% adherence, enhancing HEDIS Star ratings across triple-weighted measures for cholesterol, diabetes, and hypertension.
The program identifies high and medium-risk patients prone to adherence gaps, offering enhanced support through a clinical pharmacist team. The Company plans to expand to additional payers in 2025 and implement the program across SelectRx's pharmacy platform in 2026, reinforcing SelectQuote's evolution beyond traditional Medicare brokerage.
SelectQuote (NYSE:SLQT) announced the passing of William Thomas (Tom) Grant II, Vice Chairman and former President, on July 1, 2025. Grant played a crucial role in transforming SelectQuote from a term life insurance brokerage into a diversified insurance and healthcare services business over the past 15 years.
His sons, Bill Grant and Bob Grant, will continue their executive roles as Chief Operating Officer and President, respectively. SelectQuote, founded in 1985, operates through three core business lines: SelectQuote Senior for Medicare plans, SelectQuote Healthcare Services including SelectRx Pharmacy, and SelectQuote Life.
SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor, has achieved a Net Promoter Score (NPS) of 58, categorized as "Great" by industry standards. The company was also recently included in USA Today's "America's Best Customer Service" list for 2025. The NPS score reflects high customer satisfaction, measuring the difference between "promoters" (scores 9-10) and "detractors" (scores 1-6).
Founded in 1985, SelectQuote operates through three core business lines: SelectQuote Senior (Medicare plans), SelectQuote Healthcare Services (including SelectRx Pharmacy and chronic care management), and SelectQuote Life. The company serves approximately 10,000 people turning 65 each day with Medicare Advantage and Medicare Supplement plans through its highly-trained agents and proprietary technology.
SelectQuote (NYSE: SLQT), a leading Medicare insurance policy distributor and healthcare services platform provider, has scheduled its fiscal third quarter 2025 earnings release for May 12, 2025, before market open. The company will host a conference call on the same day at 8:30 am ET, featuring CEO Tim Danker and CFO Ryan Clement to discuss the quarterly results.
Interested participants can register for the conference call through a provided link, with registration remaining open through the live call. The event will also be available via webcast on SelectQuote's investor relations website.
SelectQuote (NYSE: SLQT) has successfully closed a $350 million strategic investment from Bain Capital, Morgan Stanley Private Credit, and Newlight Partners on February 28, 2025. The company, which specializes in Medicare insurance policy distribution and healthcare services, has allocated $260 million of the proceeds to reduce its outstanding term loan.
Following this transaction, SelectQuote now maintains over $100 million in available liquidity to support its insurance distribution and healthcare services operations. The deal also brings strategic leadership additions, with Chris Wolfe from Bain Capital Insurance and Srdjan Vukovic from Newlight Partners joining the Board of Directors, each contributing over 20 years of investing and healthcare sector expertise.